3647 results for «803»
3647 results
Rapid-fire - Challenging TAVI procedures - Part 4
20 Nov 2023 – From PCR London Valves 2023
Join this session for insights and innovative solutions to challenging TAVI procedures: explore the dynamics of peri-procedural ST-elevation myocardial infarction during TAVR, witness shifting left ventricular and hemodynamic physiology, unravel a curious case of valve-in-valve TAVR with a crossability challenge, confront the obstructive dilemma of high...
Navigating the crossroads of care: challenges in shared decision-making for doctors and patients
20 Nov 2023 – From PCR London Valves 2023
Tune in to understand the significance of shared decision-making, explore its importance, identify potential barriers, recognize the pivotal role of patient perspectives and engagement, and discover strategies to facilitate its successful integration on both local and global scales.
Top Innovations
20 Nov 2023 – From PCR London Valves 2023
Discover the future of cardiac care with these 3 top innovations! ARTERY, revolutionizing structural heart treatment, Vesalius Transfemoral DMR Repair, combining chordal and annular support in one-transfemoral device, and Approxima, a right ventricular reshaping device, offering a fresh perspective on tricuspid regurgitation.
Rapid-fire - Complex structural interventions
20 Nov 2023 – From PCR London Valves 2023
Explore groundbreaking cases in this session: choosing septal coiling over alcohol septal ablation in hypertrophic cardiomyopathy, managing a giant LAA with two Watchman Devices, treating a complex pseudoaneurysm in a patient with cardiogenic shock, and more!
Preventive PCI or medical therapy alone for atherosclerotic coronary vulnerable plaques (PREVENT)
08 Apr 2024
Ali Nazmi Calik provides his take on the results of the PREVENT trial presented at ACC.24 in Atlanta.
Author
RIVER: Rivaroxaban for valvular heart disease and atrial fibrillation
05 Sep 2023
Alex Sticchi provides his take on the results of the RIVER trial, which were presented by Pedro Gabriel Barros E Silva during the ESC 2023 congress in Amsterdam.
Rivaroxaban versus Warfarin in Patients with Bioprosthetic Valves According to Valvular Heart Disease Etiology, and Thrombotic and Bleeding Risks: Insights from...
Author
OCCUPI - Optical coherence tomography-guided coronary intervention in patients with complex lesions
03 Sep 2024
Alex Sticchi provides his take on the OCCUPI trial presented by Kim Byeong-Keuk at the ESC Congress 2024 in London.
Author
